In the last 12 months, insiders at Metagenomi Therapeutics, Inc. ($MGX) filed 89 transactions with the SEC: 2 open-market purchases totaling $13,025,000 and 20 sales totaling $98,050. Net insider sentiment: net buying.
Metagenomi Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Novo Holdings A/S (TenPercentOwner) — 5 transactions totaling $13,025,000
- Irish Jian (Chief Executive Officer) — 7 transactions totaling $405,909
- Wapnick Pamela (Chief Financial Officer) — 14 transactions totaling $227,265
- Wein Matthew (See Remarks) — 14 transactions totaling $157,176
- Thomas Brian C. (Chief Executive Officer) — 5 transactions totaling $18,874
View all SEC Filings for Metagenomi Therapeutics, Inc. (MGX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Wapnick Pamela | Chief Financial Officer | A | Stock Option (Right to Buy) | 144000 | $0.00 | 144,000.0000 | 37,546,751 | 9999.99% | 0.38% |
| April 1, 2026 | Irish Jian | See Remarks | A | Common Stock | 46000 | $0.00 | 965,197.0000 | 37,546,751 | 5.00% | 0.12% |
| April 1, 2026 | Irish Jian | See Remarks | A | Stock Option (Right to Buy) | 276000 | $0.00 | 276,000.0000 | 37,546,751 | 9999.99% | 0.74% |
| April 1, 2026 | Wein Matthew | See Remarks | A | Common Stock | 11000 | $0.00 | 125,549.0000 | 37,546,751 | 9.60% | 0.03% |
| April 1, 2026 | Wein Matthew | See Remarks | A | Stock Option (Right to Buy) | 68000 | $0.00 | 68,000.0000 | 37,546,751 | 9999.99% | 0.18% |
| April 1, 2026 | Wapnick Pamela | Chief Financial Officer | A | Common Stock | 24000 | $0.00 | 211,375.0000 | 37,546,751 | 12.81% | 0.06% |
| March 5, 2026 | Wein Matthew | See Remarks | S | Common Stock | 482 | $1.60 | 114,549.0000 | 37,546,751 | 0.42% | 0.00% |
| Dec. 5, 2025 | Irish Jian | Chief Executive Officer | G | Common Stock | 228462 | $0.00 | 920,804.0000 | 37,546,751 | 19.88% | 0.61% |
| March 5, 2026 | Irish Jian | Chief Executive Officer | S | Common Stock | 1607 | $1.60 | 919,197.0000 | 37,546,751 | 0.17% | 0.00% |
| March 5, 2026 | Wapnick Pamela | Chief Financial Officer | S | Common Stock | 1581 | $1.60 | 187,375.0000 | 37,546,751 | 0.84% | 0.00% |
| Dec. 5, 2025 | Wapnick Pamela | Chief Financial Officer | S | Common Stock | 1576 | $1.77 | 188,956.0000 | 37,546,751 | 0.83% | 0.00% |
| Dec. 5, 2025 | Irish Jian | Chief Executive Officer | S | Common Stock | 1602 | $1.77 | 563,839.0000 | 37,546,751 | 0.28% | 0.00% |
| Dec. 5, 2025 | Thomas Brian C. | Not found | S | Common Stock | 3830 | $1.77 | 2,510,960.0000 | 37,546,751 | 0.15% | 0.01% |
| Dec. 5, 2025 | Wein Matthew | See Remarks | S | Common Stock | 199 | $1.77 | 115,031.0000 | 37,546,751 | 0.17% | 0.00% |
| Sept. 5, 2025 | Wapnick Pamela | Chief Financial Officer | S | Common Stock | 1576 | $1.81 | 70,532.0000 | 1,870,923 | 2.19% | 0.08% |
| Dec. 1, 2025 | Wein Matthew | See Remarks | A | Common Stock | 96000 | $1.60 | 115,230.0000 | 37,546,751 | 499.22% | 0.26% |
| Sept. 5, 2025 | Wein Matthew | See Remarks | S | Common Stock | 199 | $1.81 | 19,230.0000 | 1,870,923 | 1.02% | 0.01% |
| Dec. 1, 2025 | Irish Jian | Chief Executive Officer | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 37,546,751 | 9999.99% | 0.60% |
| Dec. 1, 2025 | Irish Jian | Chief Executive Officer | A | Common Stock | 211000 | $1.60 | 565,441.0000 | 37,546,751 | 59.53% | 0.56% |
| Dec. 1, 2025 | Irish Jian | Chief Executive Officer | A | Common Stock | 37500 | $1.60 | 354,441.0000 | 37,546,751 | 11.83% | 0.10% |
| Sept. 5, 2025 | Irish Jian | Chief Executive Officer | S | Common Stock | 1602 | $1.81 | 316,941.0000 | 1,870,923 | 0.50% | 0.09% |
| Dec. 1, 2025 | Wapnick Pamela | Chief Financial Officer | A | Common Stock | 120000 | $1.60 | 190,532.0000 | 37,546,751 | 170.14% | 0.32% |
| Sept. 5, 2025 | Thomas Brian C. | Not found | S | Common Stock | 2701 | $1.81 | 2,514,790.0000 | 1,870,923 | 0.11% | 0.14% |
| Sept. 2, 2025 | Reid Laurence | Not found | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 1,870,923 | 9999.99% | 2.24% |
| June 10, 2025 | Dere Willard H | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 1,870,923 | 9999.99% | 1.12% |
| June 10, 2025 | BJERKHOLT ERIC | Not found | A | Stock Option (Right to Buy) | 8572 | $0.00 | 8,572.0000 | 1,870,923 | 9999.99% | 0.46% |
| June 10, 2025 | Eckhardt Juergen | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 1,870,923 | 9999.99% | 1.12% |
| June 6, 2025 | Noonberg Sarah B. | Chief Medical Officer | S | Common Stock | 5239 | $1.75 | 109,135.0000 | 1,870,923 | 4.58% | 0.28% |
| June 6, 2025 | Wein Matthew | See Remarks | S | Common Stock | 199 | $1.75 | 16,693.0000 | 1,870,923 | 1.18% | 0.01% |
| June 6, 2025 | Irish Jian | See Remarks | S | Common Stock | 6390 | $1.75 | 315,543.0000 | 1,870,923 | 1.98% | 0.34% |
| June 6, 2025 | Thomas Brian C. | Chief Executive Officer | S | Common Stock | 10785 | $1.75 | 2,517,491.0000 | 1,870,923 | 0.43% | 0.58% |
| June 6, 2025 | Wapnick Pamela | Chief Financial Officer | S | Common Stock | 1576 | $1.75 | 72,108.0000 | 1,870,923 | 2.14% | 0.08% |
| April 1, 2025 | Noonberg Sarah B. | Chief Medical Officer | A | Common Stock | 14000 | $0.00 | 114,374.0000 | 1,870,923 | 13.95% | 0.75% |
| April 1, 2025 | Noonberg Sarah B. | Chief Medical Officer | A | Stock Option (Right to Buy) | 84000 | $0.00 | 84,000.0000 | 1,870,923 | 9999.99% | 4.49% |
| April 1, 2025 | Irish Jian | See Remarks | A | Common Stock | 23000 | $0.00 | 678,898.0000 | 1,870,923 | 3.51% | 1.23% |
| April 1, 2025 | Irish Jian | See Remarks | A | Stock Option (Right to Buy) | 140000 | $0.00 | 140,000.0000 | 1,870,923 | 9999.99% | 7.48% |
| April 1, 2025 | Thomas Brian C. | Chief Executive Officer | A | Stock Option (Right to Buy) | 196000 | $0.00 | 196,000.0000 | 1,870,923 | 9999.99% | 10.48% |
| April 1, 2025 | Thomas Brian C. | Chief Executive Officer | A | Common Stock | 32000 | $0.00 | 2,528,276.0000 | 1,870,923 | 1.28% | 1.71% |
| April 1, 2025 | Wapnick Pamela | Chief Financial Officer | A | Stock Option (Right to Buy) | 84000 | $0.00 | 84,000.0000 | 1,870,923 | 9999.99% | 4.49% |
| April 1, 2025 | Wapnick Pamela | Chief Financial Officer | A | Common Stock | 14000 | $0.00 | 73,684.0000 | 1,870,923 | 23.46% | 0.75% |
| April 1, 2025 | Wein Matthew | See Remarks | A | Common Stock | 3650 | $0.00 | 13,117.0000 | 1,870,923 | 38.55% | 0.20% |
| April 1, 2025 | Wein Matthew | See Remarks | A | Common Stock | 3775 | $0.00 | 16,892.0000 | 1,870,923 | 28.78% | 0.20% |
| April 1, 2025 | Wein Matthew | See Remarks | A | Stock Option (Right to Buy) | 21875 | $0.00 | 21,875.0000 | 1,870,923 | 9999.99% | 1.17% |
| April 1, 2025 | Wein Matthew | See Remarks | A | Stock Option (Right to Buy) | 22725 | $0.00 | 22,725.0000 | 1,870,923 | 9999.99% | 1.21% |
| March 5, 2025 | Wapnick Pamela | Chief Financial Officer | S | Common Stock | 1808 | $1.87 | 59,684.0000 | 1,870,923 | 2.94% | 0.10% |
| March 5, 2025 | Wein Matthew | See Remarks | S | Common Stock | 930 | $1.87 | 9,467.0000 | 1,870,923 | 8.94% | 0.05% |
| Feb. 3, 2025 | BJERKHOLT ERIC | Not found | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 1,870,923 | 9999.99% | 2.24% |
| Dec. 5, 2024 | Wapnick Pamela | Chief Financial Officer | S | Common Stock | 1559 | $1.86 | 61,492.0000 | 3,884,740 | 2.47% | 0.04% |
| Sept. 5, 2024 | Wapnick Pamela | Chief Financial Officer | S | Common Stock | 6265 | $2.88 | 63,051.0000 | 3,884,740 | 9.04% | 0.16% |
| April 1, 2024 | Eckhardt Juergen | Not found | A | Stock Option (Right to Buy) | 78636 | $0.00 | 78,636.0000 | 3,884,740 | 9999.99% | 2.02% |
| April 1, 2024 | Thomas Brian C. | Chief Executive Officer | A | Stock Option (Right to Buy) | 500323 | $0.00 | 500,323.0000 | 3,884,740 | 9999.99% | 12.88% |
| April 1, 2024 | Thomas Brian C. | Chief Executive Officer | A | Common Stock | 118992 | $0.00 | 2,496,276.0000 | 3,884,740 | 5.01% | 3.06% |
| April 1, 2024 | Dere Willard H | Not found | A | Stock Option (Right to Buy) | 78636 | $0.00 | 78,636.0000 | 3,884,740 | 9999.99% | 2.02% |
| April 1, 2024 | Delaney Simren | See Remarks | A | Stock Option (Right to Buy) | 29145 | $0.00 | 29,145.0000 | 3,884,740 | 9999.99% | 0.75% |
| April 1, 2024 | Delaney Simren | See Remarks | A | Common Stock | 6931 | $0.00 | 93,892.0000 | 3,884,740 | 7.97% | 0.18% |
| April 1, 2024 | Harnest Simon | See Remarks | A | Stock Option (Right to Buy) | 48575 | $0.00 | 48,575.0000 | 3,884,740 | 9999.99% | 1.25% |
| April 1, 2024 | Harnest Simon | See Remarks | A | Common Stock | 11552 | $0.00 | 122,664.0000 | 3,884,740 | 10.40% | 0.30% |
| April 1, 2024 | Bernales Sebastian | Not found | A | Stock Option (Right to Buy) | 78636 | $0.00 | 78,636.0000 | 3,884,740 | 9999.99% | 2.02% |
| April 1, 2024 | Noonberg Sarah B. | Chief Medical Officer | A | Stock Option (Right to Buy) | 242875 | $0.00 | 242,875.0000 | 3,884,740 | 9999.99% | 6.25% |
| April 1, 2024 | Noonberg Sarah B. | Chief Medical Officer | A | Common Stock | 57763 | $0.00 | 100,374.0000 | 3,884,740 | 135.56% | 1.49% |
| April 1, 2024 | Wapnick Pamela | Chief Financial Officer | A | Stock Option (Right to Buy) | 291450 | $0.00 | 291,450.0000 | 3,884,740 | 9999.99% | 7.50% |
| April 1, 2024 | Wapnick Pamela | Chief Financial Officer | A | Common Stock | 69316 | $0.00 | 69,316.0000 | 3,884,740 | 9999.99% | 1.78% |
| April 1, 2024 | Wein Matthew | See Remarks | A | Stock Option (Right to Buy) | 43717 | $0.00 | 43,717.0000 | 3,884,740 | 9999.99% | 1.13% |
| April 1, 2024 | Wein Matthew | See Remarks | A | Common Stock | 10397 | $0.00 | 10,397.0000 | 3,884,740 | 9999.99% | 0.27% |
| April 1, 2024 | Borges Luis | Chief Scientific Officer | A | Stock Option (Right to Buy) | 291450 | $0.00 | 291,450.0000 | 3,884,740 | 9999.99% | 7.50% |
| April 1, 2024 | Borges Luis | Chief Scientific Officer | A | Common Stock | 69316 | $0.00 | 69,316.0000 | 3,884,740 | 9999.99% | 1.78% |
| April 1, 2024 | Irish Jian | See Remarks | A | Stock Option (Right to Buy) | 296308 | $0.00 | 296,308.0000 | 3,884,740 | 9999.99% | 7.63% |
| April 1, 2024 | Irish Jian | See Remarks | A | Common Stock | 70471 | $0.00 | 655,898.0000 | 3,884,740 | 12.04% | 1.81% |
| Feb. 13, 2024 | Novo Holdings A/S | TenPercentOwner | C | SERIES B-1 PREFERRED STOCK | 691760 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 17.81% |
| Feb. 13, 2024 | Novo Holdings A/S | TenPercentOwner | C | SERIES B PREFERRED STOCK | 147415 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 3.79% |
| Feb. 13, 2024 | BAYER HEALTHCARE LLC | TenPercentOwner | C | Common Stock | 1770888 | $0.00 | 1,770,888.0000 | 3,884,740 | 9999.99% | 45.59% |
| Feb. 13, 2024 | BAYER HEALTHCARE LLC | TenPercentOwner | C | Common Stock | 1180592 | $0.00 | 2,951,480.0000 | 3,884,740 | 66.67% | 30.39% |
| Feb. 13, 2024 | BAYER HEALTHCARE LLC | TenPercentOwner | C | Common Stock | 589662 | $0.00 | 3,541,142.0000 | 3,884,740 | 19.98% | 15.18% |
| Feb. 13, 2024 | BAYER HEALTHCARE LLC | TenPercentOwner | C | Common Stock | 509855 | $0.00 | 4,050,997.0000 | 3,884,740 | 14.40% | 13.13% |
| Feb. 13, 2024 | BAYER HEALTHCARE LLC | TenPercentOwner | C | Series A-1 Convertible Preferred Stock | 3093580 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 79.63% |
| Feb. 13, 2024 | BAYER HEALTHCARE LLC | TenPercentOwner | C | Series A-4 Convertible Preferred Stock | 2062387 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 53.09% |
| Feb. 13, 2024 | BAYER HEALTHCARE LLC | TenPercentOwner | C | Series B Convertible Preferred Stock | 1030086 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 26.52% |
| Feb. 13, 2024 | BAYER HEALTHCARE LLC | TenPercentOwner | C | Series B-1 Convertible Preferred Stock | 890671 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 22.93% |
| Feb. 13, 2024 | Novo Holdings A/S | TenPercentOwner | C | COMMON STOCK | 839175 | $0.00 | 939,175.0000 | 3,884,740 | 839.18% | 21.60% |
| Feb. 9, 2024 | Novo Holdings A/S | TenPercentOwner | P | COMMON STOCK | 100000 | $10.25 | 100,000.0000 | 3,884,740 | 9999.99% | 2.57% |
| Feb. 13, 2024 | Novo Holdings A/S | TenPercentOwner | P | COMMON STOCK | 800000 | $15.00 | 1,739,175.0000 | 3,884,740 | 85.18% | 20.59% |
| Feb. 13, 2024 | Bernales Sebastian | Not found | C | Series A-3 Preferred Stock | 119699 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 3.08% |
| Feb. 13, 2024 | Bernales Sebastian | Not found | C | Series A-4 Preferred Stock | 423469 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 10.90% |
| Feb. 13, 2024 | Bernales Sebastian | Not found | C | Series A-4 Preferred Stock | 2062387 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 53.09% |
| Feb. 13, 2024 | Bernales Sebastian | Not found | C | Series B Preferred Stock | 1143905 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 29.45% |
| Feb. 13, 2024 | Bernales Sebastian | Not found | C | Series B-1 Preferred Stock | 106627 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 2.74% |
| Feb. 13, 2024 | Bernales Sebastian | Not found | C | Common Stockc | 513004 | $0.00 | 769,845.0000 | 3,884,740 | 199.74% | 13.21% |
| Feb. 13, 2024 | Bernales Sebastian | Not found | C | Common Stock | 1896445 | $0.00 | 2,298,941.0000 | 3,884,740 | 471.17% | 48.82% |
| Feb. 13, 2024 | Bernales Sebastian | Not found | C | Series A-2 Preferred Stock | 353005 | $0.00 | 0.0000 | 3,884,740 | 100.00% | 9.09% |